In your experience, what have most studies about CGM demonstrated?
- HbA1c is lower in CGM users regardless of age or type of insulin delivery.
- Patients using MDI + CGM have greater reductions in HbA1c than those using CSII + CGM.
- Reductions in glycemic variability and time spent in hypoglycemia are not significantly different between SAP and MDI/RT-CGM therapy groups.
- All of the above
Follow the link to see how you and your colleagues compare.Read More »